Omega‐3 polyunsaturated fatty acids in the treatment of non‐alcoholic fatty liver disease: An umbrella systematic review and meta‐analysis
Abstract
There has been conflicting evidence from meta‐analyses on the effect of polyunsaturated fatty acids (PUFA) on non‐alcoholic fatty liver disease (NAFLD). Therefore, in this umbrella meta‐analysis, we are evaluating whether omega‐3 PUFA supplementation has any benefit in treating NAFLD. Electronic databases such as PubMed, Web of Science, Scopus, Embase and Google Scholar were assessed to October 2022. This meta‐analysis included all meta‐analyses that examined the effect of PUFAs on liver fat and liver function tests [aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma‐glutamyl transferase (GGT)]. Meta‐analysis was conducted using a random effects model. Subgroup analyses and sensitivity analyses were also performed. In total, eight articles involving 6,561 participants met the eligibility criteria. Advantageous impacts PUFA supplementation were observed on ALT (ESWMD = −6.72 IU/L; 95% CI: −8.61, −4.84; p < 0.001, and ESSMD = −0.52 IU/L; 95% CI: −0.84, −0.20, p < 0.001), AST (ESWMD = −3.73 IU/L, 95% CI: −5.93, −1.53, p < 0.001, and ESSMD = −0.65 IU/L; 95% CI: −1.08, −0.22, p = 0.003), GGT levels (ESWMD = −4.20 IU/L, 95% CI: −6.85, −1.55, p = 0.002), and liver fat (ESWMD = −5.16; 95% CI: −8.49, −1.82, p < 0.001). Intervention with omega‐3 PUFAs improves ALT, AST, GGT, and liver fat in patients with NAFLD. Thus, omega‐3 PUFAs could be considered as a therapeutic option in the treatment of NAFLD.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 6,561 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.